Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00822107 · ClinicalTrials.gov registry record · NA
A Translational Approach to Gitelman Syndrome
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00822107: Completed NA study, sponsored by Oregon Health and Science University.
NCT00822107 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00822107, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study will test the response to a single dose of thiazide diuretic as a diagnostic test for Gitelman syndrome. Individuals with hypokalemic alkalosis will be enrolled. After a baseline study, they will have the response to 50 mg hydrochlorothiazide on fractional chloride excretion examined.
Primary Outcome
Change from baseline in fractional chloride excretion in response to a single dose of hydrochlorothiazide
Interventions
- DRUG Hydrochlorothiazide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2009-01 |
| Est. Completion | 2013-09 |
| Phase | NA |
What the finished NCT00822107 record still lists
NCT00822107 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Hydrochlorothiazide is the first listed.
NCT00822107 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00822107 about?
NCT00822107 is a clinical study titled "A Translational Approach to Gitelman Syndrome". This study will test the response to a single dose of thiazide diuretic as a diagnostic test for Gitelman syndrome. Individuals with hypokalemic alkalosis will be enrolled. After a baseline study, they will have the response to 50 mg hydrochlorothiazide on fractional chloride excretion examined.
What is the current status of trial NCT00822107?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2009-01. Estimated completion is 2013-09.
What interventions are being tested in trial NCT00822107?
The interventions under investigation include: Hydrochlorothiazide (DRUG).
Who is sponsoring clinical trial NCT00822107?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00822107's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia